These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 9878889
1. Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's disease: mechanism of neuron death. Burke WJ, Li SW, Schmitt CA, Xia P, Chung HD, Gillespie KN. Brain Res; 1999 Jan 23; 816(2):633-7. PubMed ID: 9878889 [Abstract] [Full Text] [Related]
4. Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells. Burke WJ, Schmitt CA, Gillespie KN, Li SW. Brain Res; 1996 May 25; 722(1-2):232-5. PubMed ID: 8813375 [Abstract] [Full Text] [Related]
10. Altered expression of tyrosine hydroxylase in the locus coeruleus noradrenergic system in citalopram neonatally exposed rats and monoamine oxidase a knock out mice. Zhang J, Darling RD, Paul IA, Simpson KL, Chen K, Shih JC, Lin RC. Anat Rec (Hoboken); 2011 Oct 25; 294(10):1685-97. PubMed ID: 21901841 [Abstract] [Full Text] [Related]
11. Monoamine oxidase activity in noradrenaline neurons of the locus coeruleus of the rat. A double-labeling histochemical study. Hida T, Arai R. Brain Res; 1998 Dec 14; 814(1-2):209-12. PubMed ID: 9838121 [Abstract] [Full Text] [Related]
12. Noradrenaline-degrading activity of monoamine oxidase is localized in noradrenergic neurons of the locus coeruleus of the rat. Hasegawa Y, Hida T, Arai R. Neurosci Lett; 1999 Apr 02; 264(1-3):61-4. PubMed ID: 10320014 [Abstract] [Full Text] [Related]
14. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease. Kelly SC, He B, Perez SE, Ginsberg SD, Mufson EJ, Counts SE. Acta Neuropathol Commun; 2017 Jan 21; 5(1):8. PubMed ID: 28109312 [Abstract] [Full Text] [Related]
16. Functional consequences of locus coeruleus degeneration in Alzheimer's disease. Weinshenker D. Curr Alzheimer Res; 2008 Jun 01; 5(3):342-5. PubMed ID: 18537547 [Abstract] [Full Text] [Related]
17. ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease. Kang SS, Ahn EH, Liu X, Bryson M, Miller GW, Weinshenker D, Ye K. Acta Neuropathol; 2021 Jul 01; 142(1):139-158. PubMed ID: 33895869 [Abstract] [Full Text] [Related]
18. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. Chan-Palay V, Asan E. J Comp Neurol; 1989 Sep 15; 287(3):373-92. PubMed ID: 2570794 [Abstract] [Full Text] [Related]
19. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging. Satoh A, Iijima KM. Brain Res; 2019 Jan 01; 1702():17-28. PubMed ID: 29274876 [Abstract] [Full Text] [Related]
20. Norepinephrine transmitter metabolite generates free radicals and activates mitochondrial permeability transition: a mechanism for DOPEGAL-induced apoptosis. Burke WJ, Kristal BS, Yu BP, Li SW, Lin TS. Brain Res; 1998 Mar 23; 787(2):328-32. PubMed ID: 9518674 [Abstract] [Full Text] [Related] Page: [Next] [New Search]